Trials / Conditions / Waldenström's Macroglobulinemia (WM)
Waldenström's Macroglobulinemia (WM)
4 registered clinical trials studyying Waldenström's Macroglobulinemia (WM) — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Zanubrutinib Combined With BR in the First-line Treatment of Waldenström's Macroglobulinemia NCT06942507 | Peking Union Medical College Hospital | N/A |
| Active Not Recruiting | Retrospective-prospective Study to Evaluate Treatment Management and Outcomes of Patients With Waldenström's M NCT06441214 | Fondazione Italiana Linfomi - ETS | — |
| Recruiting | Registry Platform Hematologic Malignancies (RUBIN) - Extension of Tumor Registry Lymphatic Neoplasms NCT06043011 | iOMEDICO AG | — |
| Completed | Study of BTK Inhibitor BGB-3111 in Chinese Subjects With Relapsed/Refractory Waldenström's Macroglobulinemia ( NCT03332173 | BeiGene | Phase 2 |